Earnings
AI Spending and Soft Pharma Demand Weigh on Doximity After Weak Fiscal 2027 Outlook
Doximity (DOCS) shares tumbled after the digital healthcare platform issued fiscal 2027 revenue guidance that missed Wall Street expectations as rising AI investment costs and slower pharmaceutical advertising spending pressured investor sentiment.